Gufic Biosciences
Gufic Biosciences Limited, a prominent player in the pharmaceutical and biotechnology industry, is headquartered in India. Established in 1984, the company has made significant strides in the development and manufacturing of a diverse range of products, including injectables, oral formulations, and herbal medicines. Gufic is renowned for its commitment to quality and innovation, with a strong focus on therapeutic areas such as oncology, cardiology, and gynaecology. With a robust presence in both domestic and international markets, Gufic Biosciences has achieved notable milestones, including various certifications and partnerships that enhance its market position. The company’s unique offerings, particularly in the field of biopharmaceuticals, set it apart from competitors, making it a trusted name in healthcare. Gufic continues to drive advancements in science and technology, ensuring the delivery of effective healthcare solutions worldwide.
DitchCarbon Score
How does Gufic Biosciences's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Gufic Biosciences's score of 0 is lower than 86% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Gufic Biosciences's reported carbon emissions
In 2023, Gufic Biosciences reported total carbon emissions of approximately 2,152,589 kg CO2e for Scope 1 and about 2,330,703 kg CO2e for Scope 2. This represents a notable increase from 2022, where emissions were about 1,762,486 kg CO2e for Scope 1 and approximately 2,061,013 kg CO2e for Scope 2. For 2024, the company anticipates further emissions of around 2,500,959 kg CO2e for Scope 1 and about 2,338,070 kg CO2e for Scope 2. The emissions intensity for Scope 1 and Scope 2 combined was reported at 9,670.0 tonnes per unit of revenue in 2023, increasing to 11,630.0 tonnes in 2024. Currently, Gufic Biosciences has not established specific reduction targets or climate pledges, indicating a potential area for future commitment in their sustainability strategy. The company operates within a global context, where increasing emissions highlight the need for enhanced climate action and accountability in the biosciences sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 1,762,486.2 | 0,000,000 | 0,000,000 |
| Scope 2 | 2,061,013.2 | 0,000,000 | 0,000,000 |
| Scope 3 | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Gufic Biosciences is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
